Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Gordon

Showing results (131-140 of 286) with videos related to

Pageof 29
Sort By:
ACS Applied Materials & Interfaces|March 3, 2021
Photoenhanced Degradation of Sarin at Cu/TiO<sub>2</sub> Composite Aerogels: Roles of Bandgap Excitation and Surface Plasmon ExcitationPaul A DeSario, Wesley O Gordon, Alex Balboa, et al.
JAMA Ophthalmology|June 5, 2020
Evaluation of a Primary Open-Angle Glaucoma Prediction Model Using Long-term Intraocular Pressure Variability Data: A Secondary Analysis of 2 Randomized Clinical TrialsMae O Gordon, Feng Gao, Julia Beiser Huecker, et al.
Journal of the Mississippi State Medical Association|November 1, 1984
Percutaneous renal calculi removalH Milam, J W Evans, J P Elliott, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1989
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trialM A Kass, M O Gordon, M R Hoff, et al.
Journal of Glaucoma|November 19, 2009
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1)M A Kass, M O Gordon, M R Hoff, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 8, 2014
Correlation between papilledema grade and diffusion-weighted magnetic resonance imaging in idiopathic intracranial hypertensionDavid M Salvay, Leena V Padhye, Julie B Huecker, et al.
Cornea|January 23, 1999
Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detectionJ T Barr, K B Schechtman, B A Fink, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 15, 2005
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment StudyJohn L Keltner, Chris A Johnson, Richard A Levine, et al.
American Journal of Ophthalmology|August 9, 2005
Differences in keratoconus as a function of genderBarbara A Fink, Heidi Wagner, Karen Steger-May, et al.
Eye (London, England)|February 14, 2024
Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the discAri Leshno, Nikhil Bommakanti, Carlos Gustavo De Moraes, et al.
Pageof 29

Showing results (131-140 of 286) with videos related to

Sort By:
Pageof 29
ACS Applied Materials & Interfaces|March 3, 2021
Photoenhanced Degradation of Sarin at Cu/TiO<sub>2</sub> Composite Aerogels: Roles of Bandgap Excitation and Surface Plasmon ExcitationPaul A DeSario, Wesley O Gordon, Alex Balboa, et al.
JAMA Ophthalmology|June 5, 2020
Evaluation of a Primary Open-Angle Glaucoma Prediction Model Using Long-term Intraocular Pressure Variability Data: A Secondary Analysis of 2 Randomized Clinical TrialsMae O Gordon, Feng Gao, Julia Beiser Huecker, et al.
Journal of the Mississippi State Medical Association|November 1, 1984
Percutaneous renal calculi removalH Milam, J W Evans, J P Elliott, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1989
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trialM A Kass, M O Gordon, M R Hoff, et al.
Journal of Glaucoma|November 19, 2009
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1)M A Kass, M O Gordon, M R Hoff, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 8, 2014
Correlation between papilledema grade and diffusion-weighted magnetic resonance imaging in idiopathic intracranial hypertensionDavid M Salvay, Leena V Padhye, Julie B Huecker, et al.
Cornea|January 23, 1999
Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detectionJ T Barr, K B Schechtman, B A Fink, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 15, 2005
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment StudyJohn L Keltner, Chris A Johnson, Richard A Levine, et al.
American Journal of Ophthalmology|August 9, 2005
Differences in keratoconus as a function of genderBarbara A Fink, Heidi Wagner, Karen Steger-May, et al.
Eye (London, England)|February 14, 2024
Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the discAri Leshno, Nikhil Bommakanti, Carlos Gustavo De Moraes, et al.
Pageof 29